Danvy; Denis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Danvy; Denis.The latest application filed is for "benzazole derivatives as histamine h4 receptor ligands".

Company Profile

0.13.10

Danvy; Denis - Yvetot FR
Danvy; Denis - Mont Saint Aignan FR
Danvy; Denis - Cany Barville FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzazole derivatives as histamine H4 receptor ligands Grant 9,029,357 - Berrebi-Bertrand , et al. May 12, 2	2015-05-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20150004181 - BERREBI-BERTRAND; Isabelle ; et al.	2015-01-01
Benzazole derivatives as histamine H4 receptor ligands Grant 8,802,664 - Berrebi-Bertrand , et al. August 12, 2	2014-08-12
Carbonylated (aza) cyclohexanes as dopamine D.sub.3 receptor ligands Grant 8,802,678 - Capet , et al. August 12, 2	2014-08-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20130231329 - Berrebi-Bertrand; Isabelle ; et al.	2013-09-05
Carbonylated (aza) Cyclohexanes As Dopamine D3 Receptor Ligands App 20090286801 - Capet; Marc ; et al.	2009-11-19
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents Grant 7,432,269 - Capet , et al. October 7, 2	2008-10-07
Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands App 20080214542 - Capet; Marc ; et al.	2008-09-04
Novel Arylpiperazine Derivatives App 20080167320 - Capet; Marc ; et al.	2008-07-10
LTA.sub.4 hydrolase inhibitors Grant 7,094,773 - Danvy , et al. August 22, 2	2006-08-22
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents App 20060089364 - Capet; Marc ; et al.	2006-04-27
LTA4 hydrolase inhibitors Grant 6,878,723 - Danvy , et al. April 12, 2	2005-04-12
LTA4 hydrolase inhibitors App 20050027013 - Danvy, Denis ; et al.	2005-02-03
Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids Grant 6,835,851 - Monteil , et al. December 28, 2	2004-12-28
Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them Grant 6,767,921 - Capet , et al. July 27, 2	2004-07-27
Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them App 20030203965 - Capet, Marc ; et al.	2003-10-30
Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids App 20020055645 - Monteil, Thierry ; et al.	2002-05-09
Amino acids derivatives, the process for their preparation and their applications to therapy Grant 5,846,956 - Plaquevent , et al. December 8, 1	1998-12-08
Amino acid derivatives, the process for their preparation and their applications to therapy Grant 5,599,951 - Plaquevent , et al. February 4, 1	1997-02-04
Process for the preparation of amino acid-derived enatiomeric compounds Grant 5,136,076 - Duhamel , et al. August 4, 1	1992-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.